CervoMed Inc. Amortization of Debt Issuance Costs and Discounts
CervoMed Inc. (CRVO) reported Amortization of Debt Issuance Costs and Discounts of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2017-03-31
- CervoMed Inc. amortization of debt issuance costs and discounts for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- CervoMed Inc. amortization of debt issuance costs and discounts for fiscal 2015 was $147.15K.
| Period end | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-31 |
| 2015-12-31 | $147.15K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |